Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug will cure illness or bring relief to patients. Inspired, the team jumps in with a sense of urgency – but ...
Category Archives : Market Report V8 I2
Safety in the Spotlight: A Risk-based Approach to Biosimilars
Apr 15, 2016
Biosimilars have important cost benefits to offer the overall healthcare system, and they give access to treatment for patients with rare or very serious illnesses that can benefit from biologics. At the same time, however, biosimilars are very new to ...